- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rosiglitazone insulin sensitizing agent
Total 2905 results
-
St. Luke's-Roosevelt Hospital CenterCompletedHIV Infections | Obesity | Insulin ResistanceUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCongestive Heart FailureUnited States
-
SanofiCompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom, Netherlands, Austria, Spain, France, Germany, Ireland, Switzerland, Finland
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2 | Type 2 Diabetes MellitusChina
-
J JESUS VENEGAS, MDInstituto Mexicano del Seguro Social; National Council of Science and Technology...Completed
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIndia, Macedonia, The Former Yugoslav Republic of, Russian Federation, Turkey, Croatia, Australia, Philippines
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
China Medical University HospitalCompletedType 2 Diabetes Mellitus With Features of Insulin ResistanceTaiwan
-
Odense University HospitalCompletedType 2 Diabetes MellitusDenmark
-
Solvay PharmaceuticalsCompletedType 2 Diabetes MellitusUnited Kingdom
-
Indonesia UniversityUnknownDiabetes MellitusIndonesia
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentUnknownInsulin-requiring Type 2 Diabetes MellitusGermany
-
GeropharmCompletedDiabetes Mellitus, Type 2Russian Federation
-
SanofiCompletedType 2 Diabetes MellitusUkraine
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Austria, Switzerland, United Kingdom, Germany, Ireland
-
Centre Hospitalier Universitaire DijonCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark, Sweden, Norway
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Arab Emirates, Malaysia, India, South Africa, Algeria, Lebanon
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Egypt
-
CPEX Pharmaceuticals Inc.Completed
-
Ain Shams UniversityCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesItaly
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2
-
GlaxoSmithKlineCompletedNeuropathy, DiabeticNetherlands
-
Medstar Health Research InstituteGlaxoSmithKlineTerminated
-
Baskent UniversityCompletedObesity | Type 2 Diabetes MellitusTurkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1China
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Germany, Switzerland
-
Emory UniversitySanofi; University of MiamiCompletedHyperglycemia | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Spain, Germany, Finland, France
-
IKFE Institute for Clinical Research and DevelopmentCompleted
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTurkey
-
CPEX Pharmaceuticals Inc.WithdrawnType 1 Diabetes Mellitus
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Completed
-
Jonsson Comprehensive Cancer CenterNational Institutes of Health (NIH)TerminatedBrain and Central Nervous System TumorsUnited States
-
GlaxoSmithKlineTerminatedAlzheimer's DiseaseAustralia, Spain, United States, Bulgaria, Germany, Belgium, Canada, Hong Kong, Korea, Republic of, Portugal, Argentina, Chile, Greece, Slovenia, Czechia, France, Hungary, Italy, South Africa, India, Sweden, Netherlands, Philippines, ... and more
-
Stanford UniversityTerminatedDilated CardiomyopathyUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)UnknownHead and Neck CancerUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Poland, Russian Federation, Spain, Sweden, Netherlands, Singapore, Malaysia, France, Croatia, Romania, United Kingdom, Hong Kong
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedHealthy | DiabetesJapan